1h Free Analyst Time
The transdermal patches market is forecasted to grow by USD 2.00 bn during 2023-2028, accelerating at a CAGR of 5.65% during the forecast period. The report on the transdermal patches market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for non-invasive drug delivery methods, increasing prevalence of chronic diseases, and rising healthcare expenditure owing to increasing investment in transdermal patch development.
The transdermal patches market is segmented as below:
By Application
- Pain management
- Central nervous system disorders
- Hormonal application
- Cardiovascular diseases
- Others
By End-user
- Homecare
- Hospitals and clinics
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the transdermal patches market covers the following areas:
- Transdermal patches market sizing
- Transdermal patches market forecast
- Transdermal patches market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global transdermal patches market: Alvogen Iceland ehf, Boehringer Ingelheim International GmbH, Endo International Plc, Hisamitsu Pharmaceutical Co. Inc., IontoPatch, Johnson and Johnson Services Inc., Lead Chemical Co. Ltd., Luye Pharma Group Ltd., Medherant Ltd., Mundipharma International Ltd., Nitto Denko Corp., Novartis AG, Purdue Pharma LP, Sparsha Pharma International Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., AdhexPharma SAS, Agile Therapeutics Inc., Bayer AG, and Evernow Inc.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the development of microneedle patches for enhanced drug delivery efficiency."
According to the report, one of the major drivers for this market is the growing demand for non-invasive drug delivery methods.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alvogen Iceland ehf
- Boehringer Ingelheim International GmbH
- Endo International Plc
- Hisamitsu Pharmaceutical Co. Inc.
- IontoPatch
- Johnson and Johnson Services Inc.
- Lead Chemical Co. Ltd.
- Luye Pharma Group Ltd.
- Medherant Ltd.
- Mundipharma International Ltd.
- Nitto Denko Corp.
- Novartis AG
- Purdue Pharma LP
- Sparsha Pharma International Pvt. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- AdhexPharma SAS
- Agile Therapeutics Inc.
- Bayer AG
- Evernow Inc.
